- Home
- NERV vs SPPL Comparison
NERV vs SPPL Comparison
Compare NERV & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- SPPL
- Stock Information
- Founded
- NERV 2007
- SPPL 2016
- Country
- NERV United States
- SPPL Singapore
- Employees
- NERV N/A
- SPPL N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- SPPL
- Sector
- NERV Health Care
- SPPL
- Exchange
- NERV Nasdaq
- SPPL Nasdaq
- Market Cap
- NERV 12.0M
- SPPL 9.8M
- IPO Year
- NERV 2014
- SPPL 2023
- Fundamental
- Price
- NERV $2.35
- SPPL $3.11
- Analyst Decision
- NERV Hold
- SPPL
- Analyst Count
- NERV 1
- SPPL 0
- Target Price
- NERV $5.00
- SPPL N/A
- AVG Volume (30 Days)
- NERV 41.4K
- SPPL 17.5K
- Earning Date
- NERV 11-04-2025
- SPPL 01-01-0001
- Dividend Yield
- NERV N/A
- SPPL N/A
- EPS Growth
- NERV N/A
- SPPL N/A
- EPS
- NERV 1.48
- SPPL N/A
- Revenue
- NERV N/A
- SPPL $2,764,846.00
- Revenue This Year
- NERV N/A
- SPPL N/A
- Revenue Next Year
- NERV N/A
- SPPL N/A
- P/E Ratio
- NERV $1.58
- SPPL N/A
- Revenue Growth
- NERV N/A
- SPPL N/A
- 52 Week Low
- NERV $1.15
- SPPL $2.16
- 52 Week High
- NERV $3.00
- SPPL $16.80
- Technical
- Relative Strength Index (RSI)
- NERV 59.22
- SPPL 50.26
- Support Level
- NERV $2.26
- SPPL $2.97
- Resistance Level
- NERV $2.47
- SPPL $3.20
- Average True Range (ATR)
- NERV 0.15
- SPPL 0.18
- MACD
- NERV -0.01
- SPPL -0.00
- Stochastic Oscillator
- NERV 36.71
- SPPL 33.45
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.